Technical Analysis for IMC - Immuron Limited  

Grade Last Price % Change Price Change
F 0.074 -1.33% -0.001
IMC closed unchanged on Friday, November 22, 2024, on 45 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction -1.33%
Narrow Range Bar Range Contraction -1.33%
Gapped Up Strength -1.33%
Bollinger Band Squeeze Range Contraction -1.33%
Narrow Range Bar Range Contraction -1.33%
Earnings Movers Other -1.33%
BB Squeeze Started Range Contraction -1.33%
Fell Below 20 DMA Bearish -1.33%
Narrow Range Bar Range Contraction -1.33%
Gapped Down Weakness -1.33%

   Recent Intraday Alerts

Alert Time
Fell Below Previous Day's Low 7 minutes ago
10 DMA Resistance 7 minutes ago
2x Volume Pace 7 minutes ago
Down 1% 7 minutes ago
1.5x Volume Pace 7 minutes ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Immuron Limited   Description

Immuron Limited is a biopharmaceutical company. The Company focuses on the research and development of bovine-colostrum enriched with antibodies of choice for the treatment and prevention of a range of infections and immune modulated diseases. The Company has three segments: Research and Development (R&D), HyperImmune Products and Corporate. The R&D segment focuses on the Company's research and development projects performed in Australia and Israel. The Company sells and licenses its product, Travelan. The HyperImmune Products segment is engaged in its Travelan product's activities, which occur in Australia, New Zealand and Canada. The Corporate segment's activities primarily occur in Australia. It also develops products for applications, including non-alcoholic steatohepatitis (NASH), alcoholic steatohepatitis (ASH) and clostridium difficile (C-Diff), diabetes, colitis and uropathogenic escherichia coli (UPEC). The Company also offers Protectyn, IMM 124-E-NASH and IMM 529-CDI.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Disease Travel Diseases Biopharmaceutical Medical Specialties Prevention Infection Diabetes Infectious Diseases Hepatitis Infections Antibodies Colostrum Steatohepatitis

Is IMC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.17
52 Week Low 0.065
Average Volume 267,279
200-Day Moving Average 0.092
50-Day Moving Average 0.089
20-Day Moving Average 0.077
10-Day Moving Average 0.075
Average True Range 0.003
RSI (14) 37.50
ADX 26.46
+DI 25.301
-DI 31.325
Chandelier Exit (Long, 3 ATRs) 0.077
Chandelier Exit (Short, 3 ATRs) 0.081
Upper Bollinger Bands 0.081
Lower Bollinger Band 0.072
Percent B (%b) 0.33
BandWidth 11.503
MACD Line -0.004
MACD Signal Line -0.004
MACD Histogram 0.0006
Fundamentals Value
Market Cap 17.01 Million
Num Shares 227 Million
EPS -0.03
Price-to-Earnings (P/E) Ratio -2.34
Price-to-Sales 18.21
Price-to-Book 10.45
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.077
Resistance 3 (R3) 0.077 0.076 0.076
Resistance 2 (R2) 0.076 0.076 0.076 0.076
Resistance 1 (R1) 0.076 0.076 0.076 0.076 0.076
Pivot Point 0.075 0.075 0.075 0.075 0.075
Support 1 (S1) 0.075 0.075 0.075 0.075 0.074
Support 2 (S2) 0.074 0.075 0.074 0.074
Support 3 (S3) 0.074 0.074 0.074
Support 4 (S4) 0.074